|
Checklist for WHO Treatment Guidelines (from Guidelines for WHO Guidelines [3]). |
|||
| Yes |
Questions |
Reference Points |
|
|
|
|||
| Origin |
|||
| 1 |
Are the Cluster and Department issuing the guidelines clearly identified? |
Introduction |
|
| Objective, target audience |
|||
| 2 |
Does the guideline list its objectives, including the patient categories and situation(s) for which the guidelines are intended? |
Introduction |
|
| 3 |
Does the guideline describe the professional groups to which it is addressed? |
Introduction |
|
| Guideline Development Group |
|||
| 4 |
Does the Guideline Development Group include all relevant professional groups, public health experts and end users, including individuals from geographic areas where the guidelines will be applied? |
List of members of the guideline development group |
|
| 5 |
Does the Group include methodological experts in fields such as search methodology, critical appraisal and cost-effectiveness analysis? |
List of members of the guideline development group |
|
| Conflict of interest |
|||
| 6 |
Are all funding sources named, and is there no conflict of interest? |
List of funding sources |
|
| 7 |
Have all members of the Guideline Development Group and external reviewers declared their interests, and have these interests been recorded in the guideline document? |
Annex on documentation of process |
|
| 8 |
Does the document describe the method used to minimize any undue influence on the Guideline Development Group and the external reviewers? |
Annex on documentation of process |
|
| Evidence |
|||
| 9 |
Was there a systematic comprehensive search for evidence, and has the search strategy been recorded in the guideline? |
Annex on documentation of process |
|
| 10 |
Has the strength and quality of the evidence on effectiveness been graded? |
Annex on documentation of process; evidence table |
|
| 11a |
What percent of recommendations are evidence-based?* |
Summary of recommendations |
|
| 11b |
Are the recommendations which are not evidence-based explicitly labeled as "expert opinion" based? |
Summary of recommendations |
|
| 12 |
Is there explicit consideration of other issues, such as safety and potential misuse in a variety of settings? |
Annex on documentation of process; evidence table |
|
| 13 |
Is there explicit consideration of issues of cost effectiveness? |
Annex on documentation of process; evidence table |
|
| 14 |
Is the strength of the recommendation linked to the evidence? |
Summary of Recommendations |
|
| 15 |
Do the recommendations take into account potential resource constraints? |
Implementation issues |
|
| Review |
|||
| 16 |
Were the comments by the external peer review adequately addressed? |
Annex on documentation of process |
|
| 17 |
Did all members of the Guideline Development Group approve the final document? |
Annex on documentation of process |
|
| 18 |
Did all members of the Steering Group approve the final document? |
Annex on documentation of process |
|
| 19 |
Is there a plan for reviewing new evidence and updating the guideline? |
Introduction |
|
| Presentation, clarity |
|||
| 20 |
Are the recommendations clearly formulated? |
Summary of Recommendations |
|
| 21 |
Does the guideline identify and advise on ineffective practices? |
Summary of Recommendations |
|
| Implementation plan |
|||
| 22 |
Is there a plan for dissemination and local adaptation of the guideline? |
Companion document |
|
| 23 |
Are funds available for dissemination and local adaptation for the guideline? |
Companion document |
|
| 24 |
Are there suggested criteria for monitoring the use in intended settings? |
Implementation Issues |
|
|
This Checklist is intended for the following purposes: (1) As a guide for developing or updating WHO treatment Guidelines. (2) As a check-list for Executive and Regional Directors when giving final approval for publication. To qualify for publication and inclusion in the WHO database of treatment guidelines, a tick mark signifying YES must be placed beside all the 24 criteria, except 11a. *These are recommendations based on information other than expert opinion. | |||
Oxman et al. Health Research Policy and Systems 2006 4:28 doi:10.1186/1478-4505-4-28 |
|||